Janet Woodcock will become acting commissioner of the US Food and Drug Administration upon Commissioner Stephen Hahn’s departure on 20 January following the inauguration of President-elect Joe Biden, leaving the agency in the hands of a career veteran who has been a lead expert in the COVID-19 response.
The move was requested by the incoming Biden team, a senior FDA official confirmed to the Pink Sheet, and the internal paperwork to support the move has been sent by the agency to the Department of Health and Human
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?